Brandon Aden - CHERISH

Bio

Brandon Aden is an assistant professor of medicine and of population health sciences at Weill Cornell Medicine, and the associate program director for the Weill Cornell Public Health and Preventive Medicine Residency. He is the primary medical care provider at the Vincent P. Dole Treatment Center in the New York Presbyterian Ambulatory Care Network, providing addiction treatment and primary medical care to patients with substance use disorders. His research focuses on quality-of-life assessment in opioid dependence and models of HCV care service delivery. Aden is board certified in Internal Medicine, Public Health and General Preventive Medicine, and Addiction Medicine.

Related Content

07/26/19 Collaborations

CHERISH Workshop Addresses an ‘Unfortunate Reality’ of the Addiction Treatment Industry

Funded by the National Institute on Drug Abuse and established in 2015, CHERISH is a five year collaboration of researchers from the Leonard Davis Institute of Health Economics (LDI) of the University of Pennsylvania, Weill Cornell Medical College, Boston Medical Center, and the University of Miami. Their work is focused on studying the health economics […]

10/02/18 Research Highlight

Impact of State Policies for Prescription Drug Monitoring Programs on High-Risk Opioid Prescriptions

A recent study in Health Affairs by CHERISH Research Affiliate Dr. Yuhua Bao and CHERISH investigators Dr. Zachary Meisel and Dr. Bruce Schackman examined the impact of prescription drug monitoring program policies on high-risk opioid prescriptions. Prescription drug monitoring programs (PDMPs) are statewide databases of controlled substances dispensed at retail pharmacies. Currently, all states and Washington D.C. except Missouri […]

06/14/17 Collaborations

CHERISH Conference on Substance Use Disorder Treatment Research

In the opening plenary panel of the CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV) conference on evidence-based policy and practice are (l to r) Daniel Polsky, PhD, moderator and Executive Director of the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI); Tom McLellan, PhD, Chairman of the Board and […]

11/29/16 Profile Feature

CHERISH Profiled at the Liver Meeting® 2016

The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]

12/16/15 Research Highlight

Quality of Life of Opioid Users and their Spouses

There are more deaths in the US from opioids than from any other unintentional injury–one person died every 30 minutes from an opioid analgesic overdose in the US in 2014. The experience of living with opioid use is harmful both for the opioid user and for his or her spouse. A recent study published in the journal Addiction quantified […]

08/18/15 Profile Feature

Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College

The high costs of treating the more than 7 million people with a substance use disorder may be daunting to public and private payers. The costs of not treating them may be even higher, especially if you consider the costs of failing to screen for and treat HIV and hepatitis C in this population. Sorting […]

Brandon Aden, MD, MPH

Bio

Engage with CHERISH